Homeopathic remedy Lycopodium Clavatum offers new hope to cancer sufferers: Study

http://www.naturalnews.com/041501_lycopodium_clavatum_cancer_treatment_homeopathic_remedy.html

NaturalNews) One of the most exciting developments in the war on cancer has just been published in the Journal of Acupuncture and Meridian Studies, where new research shows that the homeopathic remedy, Lycopodium Clavatum (a spore bearing plant from the clubmoss family), has an anti-cancer effect on infected cells while protecting normal blood cells.

The report by the Boiron Laboratory in France and the University of Kalyani in India reveals that highly diluted Lycopodium Clavatum remedies (LC-5C and LC-15C) are capable of inducing 'apoptosis' (cellular death) in cervical cancer cells, signifying their possible use as a supportive medicine in cancer therapy.

The $200 billion dollar per year cancer industry is desperate to convince you that chemotherapy, radiation, toxic drugs and surgery are the only proven treatments for the disease, faced as it is today, with rising demand for complementary and alternative cancer medicines.

Not the first time: Other homeopathic remedies fight cancer too

This isn't the first time that a homeopathic remedy has been found to be effective against cancer. Two previous studies have produced similarly exciting results. Frenkel, M. et al. (2010) used ultra-diluted remedies of Phytolacca, Carcinosin, Conium, and Thuja on breast cancer cells and witnessed a deactivation of the cancer in a process called cytotoxicity. Another team, led by Toliopoulos IK, Simos Y, Bougiouklis D and Oikonomidis S (2013), discovered that certain homeopathic complexes were able to stimulate the anti-cancer activity of Natural Killer Cells (part of our immune system) in cancer patients.

With North America holding the second highest incidence rate of cancer in the world, closely followed by Western Europe, the discovery delivers the prospect of an existing, legal and affordable alternative to conventional treatments.

Dr Alexander Tournier, Executive Director of the London-based Homeopathy Research Institute (http://www.homeoinst.org) confirmed the validity of the Boiron/Kalyani report, stating:

"This study is very significant, performed by a well trained team with access to modern molecular biology techniques and with the support of Boiron - a leading homeopathic manufacturer worldwide - thus ensuring that the homeopathy part of the experiment is taken care of correctly."

Lycopodium Clavatum could work against other types of cancer

Although cervical cancer cells were used in the study, the findings suggest that Lycopodium Clavatum could help fight other types of cancer. Dr Tournier adds:

"These results found on [cervical] cells are potentially generalisable to other cancer cell lines, although the tests would have to be done.

"The fact that homeopathic medicines were shown to be effective at selectively killing cancer cells warrants further research, and offers the possibility that homeopathy could be useful for a wide variety of cancer patients in the future."

With Lycopodium Clavatum being widely available to purchase online, it could be tempting for cancer sufferers to self-medicate. However, this would be inadvisable until further research has confirmed its safety and efficacy in patients. Dr Tournier adds:

"Lycopodium is already available to the general public. It would be very easy to purchase from a homeopathic pharmacy. However, I would not recommend taking Lycopodium for cancer, even for cervical cancer. This study does not provide evidence that the homeopathic remedy will be effective in cancer patients. More research is required before such a homeopathic medicine can be used routinely in cancer treatment."

It is nevertheless, still possible to find experienced doctors who treat cancer patients using homeopathy with a high success rate. One of these is Dr. Spinedi's team at the Clinica Santa Croce (http://www.omeopatia.clinicasantacroce.ch) in Switzerland, who use many remedies, carefully selected for the particular complaint and circumstances of each patient.